The high clinical mortality and economic burden posed by invasive fungal infections (IFIs),
along with significant agricultural crop loss caused by various fungal species, has resulted in …

Candida auris is a multidrug resistant yeast, recognized as a cause of invasive infections
and health care associated outbreaks around the world. C. auris is of great public health …

Background Emergence of coronavirus disease 2019 (COVID‐19) is a major healthcare
threat. Apparently, the novel coronavirus (SARS‐CoV‐2) is armed by special abilities to …

As a novel risk factor, COVID-19 has led to an increase in the incidence of candidemia and
an elevated mortality rate. Despite being of clinical importance, there is a lack of data …

Candida auris is a novel and major fungal pathogen that has triggered several outbreaks in
the last decade. The few drugs available to treat fungal diseases, the fact that this yeast has …

The incidence of opportunistic yeast infections in humans has been increasing over recent
years. These infections are difficult to treat and diagnose, in part due to the large number …

The multidrug-resistant yeast Candida auris is associated with invasive infections in critically
ill patients and has been isolated in different countries worldwide. Ease of spread …

The recognition of a new yeast, Candida auris, in 2009 in East Asia, and its rapid global
spread, was a reminder of the threats posed by multidrug-resistant fungal pathogens. C …

Extensive advances in technology offer a vast variety of diagnostic methods that save time
and costs, but identification of fungal species causing human infections remains challenging …

Recurrent vulvovaginal candidiasis (RVVC) is one of the most prevalent fungal infections in
humans, especially in develo** countries; however, it is underestimated and regarded as …